Elevance Health issues $2.5B in three tranches of notes

Elevance Health, Inc.

Issued $500M 4.900% Notes due 2026, $1B 4.750% Notes due 2033, $1.1B 5.125% Notes due 2053.
Net proceeds approximately $2.57B after underwriting discounts and offering expenses.
Proceeds for working capital, general corporate purposes including acquisitions, debt repayment, and share repurchases.
Notes unsecured; redeemable at par after Par Call Date; change of control put at 101%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.